Researchers have successfully repurposed a known anticancer agent into a sound-activated antibacterial drug candidate. This innovative approach leverages the unique properties of the anticancer compound, which has shown potential in targeting bacterial infections when activated by sound waves. The study highlights the compound’s ability to selectively kill bacteria without harming human cells, making it a promising alternative to traditional antibiotics.
The team utilized ultrasound to trigger the release of reactive oxygen species (ROS) from the anticancer agent. These ROS are effective in disrupting bacterial cell membranes, leading to cell death. This method not only enhances the efficacy of the drug but also minimizes side effects typically associated with conventional treatments.
As antibiotic resistance continues to rise, the development of new antibacterial strategies is critical. The researchers are optimistic about further testing and potential clinical applications, which could pave the way for innovative treatments in combating bacterial infections.
Source: news.google.com